MetaviaMTVA
13F holders, Q2 2024 (June 30)12holders −1
2new positions
3sold out
$4.84avg. 13F price*
At the end of Q2 2024, 12 institutions reported holding Metavia Inc. (MTVA) in their 13F filings, down 1 from Q1 2024. 2 opened new positions and 3 sold out. The largest holders were Armistice Capital, LLC ($3.4M), Affinity Asset Advisors, LLC ($432K) and Vanguard Group Inc. ($229K).
- Company
- Metavia Inc.
- Filed as
- NEUROBO PHARMACEUTICALS INC (Q2 2024)
- CUSIP
- 64132R404
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $3.8M |
| Exits | 3 | $51K |
All 13F filers, Q1 2024 → Q2 2024: 807,898 shares bought and 13,184 shares sold, net +794,714 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Armistice Capital, LLC | 0.09% | New | 696,829 | $3.4M |
| Affinity Asset Advisors, LLC | 0.07% | New | 89,222 | $432K |
| Vanguard Group Inc. | 0.00% | Add +69.0% | 47,348 | $229K |
| Geode Capital Management, LLC | 0.00% | Add +11.4% | 23,063 | $112K |
| State Street Corp. | 0.00% | No change | 15,633 | $76K |
| Northern Trust Corp. | 0.00% | No change | 13,508 | $65K |
| BlackRock Inc. | 0.00% | No change | 5,274 | $26K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -38.5% | 1,017 | $5K |
| Bank of America Corp. | 0.00% | Add +15900.0% | 160 | $775 |
| Morgan Stanley | 0.00% | No change | 25 | $121 |
| JPMorgan Chase & Co. | 0.00% | Reduce -37.5% | 5 | $24 |
| BNP Paribas Financial Markets | 0.00% | No change | 4 | $19 |
"% of holder's portfolio" is MTVA's weight in each manager's 13F, not the share of Metavia Inc. the manager owns.